Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by GunnerGon May 17, 2021 11:19am
52 Views
Post# 33213966

RE:RE:RE:of course, we only sold 30% of the ==>voucher<==

RE:RE:RE:of course, we only sold 30% of the ==>voucher<==I understand it really goods.  Even your alterego is trying to point out to you how wrong you are.

"will enter into" is not a maybe we will maybe we won't.  It's a definitive, one gets done and then the other follows.  Duh

Only 30%.  You were so sure we were getting the PV a short while ago.  Now 3 weeks away, they give away $30M.  I remember you thought it was worth $100M.

$30M covers Keidron's costs. 


realstocky wrote:

do you understand english? thats not part of this deal, it's an optional  agreement that will be available to Kedrion..depending of course on the FDA green lighting riplazym. IT's something to be negociated at a later dater after closing of this deal

 

dumbass:)

 

Under the Share Purchase Agreement, the parties have agreed that upon closing of the proposed sale, the Company will enter into an option agreement with Kedrion for the right to acquire the remainder of the Company's plasma-derived business, including the Ryplazim business operated through its subsidiaries, Prometic Bioproduction Inc., the Company's plasma-derived therapeutics manufacturing facility ("PBP"), and Prometic Biotherapeutics Inc. ("PBT"), holder of the biological license application ("BLA") for Ryplazim ® (Plasminogen) ("Ryplazim ® ").

 

 

GunnerG wrote: Under the Share Purchase Agreement, the parties have agreed that upon closing of the proposed sale, the Company will enter into an option agreement with Kedrion for the right to acquire the remainder of the Company's plasma-derived business, including the Ryplazim business 

Hard to make money on something you don't own unless you have royalties on revenues as TV does. You get nothing.....LOL


 

 



<< Previous
Bullboard Posts
Next >>